Evaluation of Cisplatin and DTIC in Inoperable Stage III and IV Melanoma
William S. Fletcher(Oregon Health & Science University), J Pancoast, Vernon K. Sondak(Advanced Dermatology), Laura F. Hutchins, Bruce W. Dana(Unknown), Raeann Townsend, Harry E. Hynes, Danni Daniels
Cited by 27
Related Papers
Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function.
|Journal of Clinical Oncology|1991|383
ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee
|Annals of Oncology|2020|232
Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy.
|Journal of Clinical Oncology|1993|193